Hormone Replacement Therapy and Risk of Breast Cancer in Korean Women: A Quantitative Systematic Review

Overview

Journal J Prev Med Public Health

Specialty Public Health

Date 2015 Oct 3

PMID 26429288

Citations 12

Authors

Jong-Myon Bae

Eun Hee Kim

Affiliations

Soon will be listed here.

Abstract

Objectives: The epidemiological characteristics of breast cancer incidence by age group in Korean women are unique. This systematic review aimed to investigate the association between hormone replacement therapy (HRT) and breast cancer risk in Korean women.

Methods: We searched electronic databases such as KoreaMed, KMbase, KISS, and RISS4U as well as PubMed for publications on Korean breast cancer patients. We also conducted manual searching based on references and citations in potential papers. All of the analytically epidemiologic studies that obtained individual data on HRT exposure and breast cancer occurrence in Korean women were selected. We restricted the inclusion of case-control studies to those that included age-matched controls. Estimates of summary odds ratio (SOR) with 95% confidence intervals (CIs) were calculated using random effect models.

Results: One cohort and five case-control studies were finally selected. Based on the heterogeneity that existed among the six studies (I-squared=70.2%), a random effect model was applied. The summary effect size of HRT history from the six articles indicated no statistical significance in breast cancer risk (SOR, 0.983; 95% CI, 0.620 to 1.556).

Conclusions: These facts support no significant effect of HRT history in the risk of breast cancer in Korean women. It is necessary to conduct a pooled analysis.

Citing Articles

Causes and Risk Factors of Breast Cancer, What Do We Know for Sure? An Evidence Synthesis of Systematic Reviews and Meta-Analyses.

Loyland B, Sandbekken I, Grov E, Utne I Cancers (Basel). 2024; 16(8).

PMID: 38672665 PMC: 11049405. DOI: 10.3390/cancers16081583.

Attitude, Practices, and Barriers to Menopausal Hormone Therapy Among Physicians in Saudi Arabia.

Qutob R, Alaryni A, Alsolamy E, Al Harbi K, Alammari Y, Alanazi A Cureus. 2024; 16(1):e52049.

PMID: 38344533 PMC: 10857802. DOI: 10.7759/cureus.52049.

Screening breast magnetic resonance imaging in women with hormone replacement therapy.

Zhang F, Feng Q, Zhang Z, Hu Y, Zhang Z Eur J Med Res. 2018; 23(1):48.

PMID: 30342556 PMC: 6195689. DOI: 10.1186/s40001-018-0351-8.

Menopause as a potential cause for higher prevalence of low back pain in women than in age-matched men.

Wang Y J Orthop Translat. 2018; 8:1-4.

PMID: 30035087 PMC: 5987020. DOI: 10.1016/j.jot.2016.05.012.

Frailty Is Inversely Related to Age at Menopause and Elevated in Women Who Have Had a Hysterectomy: An Analysis of the Canadian Longitudinal Study on Aging.

Verschoor C, Tamim H J Gerontol A Biol Sci Med Sci. 2018; 74(5):675-682.

PMID: 29688443 PMC: 6477649. DOI: 10.1093/gerona/gly092.

References

Do M, Lee S, Jung P, Lee M . Intake of fruits, vegetables, and soy foods in relation to breast cancer risk in Korean women: a case-control study. Nutr Cancer. 2007; 57(1):20-7. DOI: 10.1080/01635580701268063. View

Chlebowski R, Anderson G . Changing concepts: Menopausal hormone therapy and breast cancer. J Natl Cancer Inst. 2012; 104(7):517-27. PMC: 3317878. DOI: 10.1093/jnci/djs014. View

Methley A, Chew-Graham C, Campbell S, Cheraghi-Sohi S . Experiences of UK health-care services for people with Multiple Sclerosis: a systematic narrative review. Health Expect. 2014; 18(6):1844-55. PMC: 5810635. DOI: 10.1111/hex.12228. View

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Sprague B, Trentham-Dietz A, Cronin K . A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol. 2012; 120(3):595-603. PMC: 3607288. DOI: 10.1097/AOG.0b013e318265df42. View

Jung K, Won Y, Kong H, Oh C, Cho H, Lee D . Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015; 47(2):127-41. PMC: 4398120. DOI: 10.4143/crt.2015.060. View

Bae J . Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis. Epidemiol Health. 2015; 37:e2015005. PMC: 4371392. DOI: 10.4178/epih/e2015005. View

Shin A, Kim J, Lim S, Kim G, Sung M, Lee E . Dietary mushroom intake and the risk of breast cancer based on hormone receptor status. Nutr Cancer. 2010; 62(4):476-83. DOI: 10.1080/01635580903441212. View

Santen R, Allred D, Ardoin S, Archer D, Boyd N, Braunstein G . Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010; 95(7 Suppl 1):s1-s66. PMC: 6287288. DOI: 10.1210/jc.2009-2509. View

10.

Kim Y, Choi J, Lee K, Park S, Ahn S, Noh D . Dose-dependent protective effect of breast-feeding against breast cancer among ever-lactated women in Korea. Eur J Cancer Prev. 2007; 16(2):124-9. DOI: 10.1097/01.cej.0000228400.07364.52. View

11.

Bae J . Two hypotheses of dense breasts and viral infection for explaining incidence of breast cancer by age group in Korean women. Epidemiol Health. 2014; 36:e2014020. PMC: 4220604. DOI: 10.4178/epih/e2014020. View

12.

Kim B, Choi Y, Song Y, Park J, Noh H, Nguyen T . Bone mineral density and the risk of breast cancer: a case-control study of Korean women. Ann Epidemiol. 2013; 24(3):222-7. DOI: 10.1016/j.annepidem.2013.11.009. View

13.

DeSantis C, Ma J, Bryan L, Jemal A . Breast cancer statistics, 2013. CA Cancer J Clin. 2013; 64(1):52-62. DOI: 10.3322/caac.21203. View

14.

Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View

15.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin. 2013; 63(1):11-30. DOI: 10.3322/caac.21166. View

16.

Greenhalgh T, Heath I . Measuring quality in the therapeutic relationship--part 1: objective approaches. Qual Saf Health Care. 2010; 19(6):475-8. DOI: 10.1136/qshc.2010.043364. View

17.

Park I, Ko K, Joo J, Park B, Jung S, Lee S . High volumetric breast density predicts risk for breast cancer in postmenopausal, but not premenopausal, Korean Women. Ann Surg Oncol. 2014; 21(13):4124-32. DOI: 10.1245/s10434-014-3832-1. View

18.

Chlebowski R, Hendrix S, Langer R, Stefanick M, Gass M, Lane D . Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 2003; 289(24):3243-53. DOI: 10.1001/jama.289.24.3243. View

19.

Bae J . Narrative reviews. Epidemiol Health. 2014; 36:e2014018. PMC: 4207097. DOI: 10.4178/epih/e2014018. View

20.

Chlebowski R, Anderson G . Menopausal hormone therapy and cancer: changing clinical observations of target site specificity. Steroids. 2014; 90:53-9. PMC: 4192019. DOI: 10.1016/j.steroids.2014.06.001. View